Skip to main content



Local Cdiff information for Virginia

Virginia

Learn about C. diff providers, regulation, clinical trials, and advocacy efforts in Virginia.



Local Cdiff information for Virginia

Virginia

Learn about C. diff providers, regulation, clinical trials, and advocacy efforts in Virginia.

Providers


Dr. C. Taylor Richardson, MD

Richmond Gastroenterology Associates
5875 Bremo Road, Suite 601
Richmond23226
804-673-2806
FMT Provider: Yes

Dr. Amira Ibrahim

Advanced Gastroenterology Specialists
7611 Forest Ave. Suite 330
Richmond23229
(804) 219-4800
FMT Provider: Yes

Dr. Brian W. Behm, MD

Associate Professor of Medicine, University of Virginia Health System, Charlottesville, VA
Digestive Health Center
Main Floor
1215 Lee Street
Charlottesville22903
434-243-3090
FMT Provider: No

Dr. Suchitra Hourigan, MD

Pediatric Specialists of Virginia
3023 Hamaker Ct 600
Fairfax22031
703-876-2788
FMT Provider: Yes

Regulation


C. diff Infections

Total Reported Cases: 1548
Hospital Onset: 1548
Community Onset: Not reported
Related Deaths: Not reported

Available Reports

Annual Progress based on SIR: 0.62

State Reporting Laws

Data Submission Required: No
Data Publicly Available: No
Data Validated: No
Facility-specific Data Publicly Reported: No
LTC Facility Submission Required: No
LTC Facility Data Publicly Reported: No
Law/Regulation: Not available

State Contact

Andrea Alvarez, MPH
Healthcare-Associated Infections Epidemiologist
Virginia Department of Health
Division of Surveillance and Investigation
109 Governor St, 5th Floor
Richmond, 23219
804.864.8097
804.864-8139

CLINICAL TRIALS


Immune Response to C. difficile Infection

Official Title: Clostridioides Difficile and Immune Responses in Acute CDI and Fecal Microbiota Transplant
Trial No. NCT02797288
Type: Observational
Recruitment: Recruiting
Sponsor: University of Virginia
Contact: William A. Petri, MD, PhD
434-924-5621
Gender: All
Age: 18 years and older

ACT

Official Title: Alanyl-glutamine Supplementation of Standard Treatment for C. Difficile Infection: A Randomized, Double-blind, Placebo-controlled Trial
Trial No. NCT04305769
Type: Interventional
Recruitment: Recruiting
Sponsor: University of Virginia
Contact: Cirle Warren, M.D.
434-270-1082
Gender: All
Age: 18 Years to 105 Years

RESTORATiVE303

Official Title: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of VE303 for Prevention of Recurrent Clostridioides Difficile Infection
Trial No. NCT06237452
Type: Interventional
Recruitment: Recruiting
Sponsor: Vedanta Biosciences, Inc
Contact: Mary Garfield
Gender: All
Age: 12 Years and older

ROAR

Official Title: REBYOTA™ for the Prevention of Recurrence of Clostridioides Difficile Infection (CDI) in Adult Patients: An Observational Study
Trial No. NCT05835219
Type: Observational
Recruitment: Recruiting
Sponsor: Ferring Pharmaceuticals
Contact:Global Clinical Compliance
833-548-1402
Gender: All
Age: 18 Years and older